Nifty
Sensex
:
:
22147.00
73088.33
151.15 (0.69%)
599.34 (0.83%)

Pharmaceuticals & Drugs

Rating :
56/99

BSE: 543349 | NSE: AMIORG

1205.20
18-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  1246.75
  •  1254.90
  •  1190.15
  •  1232.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  149677
  •  1832.16
  •  1388.95
  •  1004.45

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,432.49
  • 106.16
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,429.34
  • 0.25%
  • 6.84

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 39.91%
  • 10.82%
  • 30.01%
  • FII
  • DII
  • Others
  • 8.98%
  • 4.23%
  • 6.05%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 23.27
  • -
  • 21.88

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 34.96
  • -
  • 8.87

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 40.10
  • -
  • 15.54

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 54.40

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 6.96

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 36.39

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
166.44
152.36
9.24%
172.36
146.99
17.26%
142.35
131.01
8.66%
186.38
143.54
29.85%
Expenses
139.94
121.56
15.12%
147.54
118.86
24.13%
117.20
108.08
8.44%
145.53
117.76
23.58%
EBITDA
26.51
30.80
-13.93%
24.81
28.12
-11.77%
25.15
22.92
9.73%
40.86
25.79
58.43%
EBIDTM
15.93%
20.21%
14.40%
19.13%
17.67%
17.50%
21.92%
17.96%
Other Income
3.49
3.02
15.56%
1.50
0.85
76.47%
1.10
0.62
77.42%
-0.17
0.18
-
Interest
2.54
1.19
113.45%
0.82
0.45
82.22%
0.51
0.18
183.33%
0.59
0.59
0.00%
Depreciation
3.76
3.06
22.88%
3.69
2.82
30.85%
3.42
3.04
12.50%
3.43
3.11
10.29%
PBT
23.70
29.57
-19.85%
-9.94
25.71
-
22.32
20.32
9.84%
36.66
22.26
64.69%
Tax
5.89
7.28
-19.09%
7.08
6.67
6.15%
5.67
5.46
3.85%
9.46
0.98
865.31%
PAT
17.81
22.28
-20.06%
-17.02
19.04
-
16.65
14.86
12.05%
27.20
21.28
27.82%
PATM
10.70%
14.62%
-9.87%
12.95%
11.70%
11.35%
14.59%
14.83%
EPS
4.54
6.12
-25.82%
-5.11
5.22
-
4.57
4.08
12.01%
7.46
5.84
27.74%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 18
Mar 17
Mar 16
Net Sales
667.53
616.73
520.13
340.61
239.64
188.22
160.26
153.70
Net Sales Growth
16.31%
18.57%
52.71%
42.13%
27.32%
17.45%
4.27%
 
Cost Of Goods Sold
380.31
330.89
272.83
179.68
128.91
112.95
95.00
91.50
Gross Profit
287.22
285.84
247.30
160.92
110.73
75.27
65.27
62.21
GP Margin
43.03%
46.35%
47.55%
47.24%
46.21%
39.99%
40.73%
40.47%
Total Expenditure
550.21
494.13
414.96
260.45
198.63
157.70
137.13
135.51
Power & Fuel Cost
-
22.28
21.40
5.26
4.54
1.27
1.00
1.26
% Of Sales
-
3.61%
4.11%
1.54%
1.89%
0.67%
0.62%
0.82%
Employee Cost
-
48.84
41.37
21.01
17.81
9.89
7.38
7.02
% Of Sales
-
7.92%
7.95%
6.17%
7.43%
5.25%
4.61%
4.57%
Manufacturing Exp.
-
46.98
49.66
41.32
34.60
19.87
15.42
14.41
% Of Sales
-
7.62%
9.55%
12.13%
14.44%
10.56%
9.62%
9.38%
General & Admin Exp.
-
9.93
7.30
4.46
4.72
8.59
13.68
15.24
% Of Sales
-
1.61%
1.40%
1.31%
1.97%
4.56%
8.54%
9.92%
Selling & Distn. Exp.
-
26.49
19.92
7.01
5.79
3.97
3.92
5.36
% Of Sales
-
4.30%
3.83%
2.06%
2.42%
2.11%
2.45%
3.49%
Miscellaneous Exp.
-
8.71
2.49
1.72
2.26
1.16
0.74
0.73
% Of Sales
-
1.41%
0.48%
0.50%
0.94%
0.62%
0.46%
0.47%
EBITDA
117.33
122.60
105.17
80.16
41.01
30.52
23.13
18.19
EBITDA Margin
17.58%
19.88%
20.22%
23.53%
17.11%
16.22%
14.43%
11.83%
Other Income
5.92
4.32
2.76
1.38
2.84
2.96
0.21
2.87
Interest
4.46
2.41
6.41
5.62
5.59
3.23
3.30
2.56
Depreciation
14.30
12.34
10.08
4.19
3.52
1.91
1.37
0.80
PBT
72.74
112.17
91.45
71.73
34.75
28.35
18.68
17.70
Tax
28.10
28.88
19.50
17.73
7.28
9.85
6.63
5.04
Tax Rate
38.63%
25.75%
21.32%
24.72%
20.95%
34.74%
35.49%
28.47%
PAT
44.64
83.29
71.95
54.00
27.47
18.50
12.05
12.66
PAT before Minority Interest
41.75
83.29
71.95
54.00
27.47
18.50
12.05
12.66
Minority Interest
-2.89
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
6.69%
13.51%
13.83%
15.85%
11.46%
9.83%
7.52%
8.24%
PAT Growth
-42.37%
15.76%
33.24%
96.58%
48.49%
53.53%
-4.82%
 
EPS
12.10
22.57
19.50
14.63
7.44
5.01
3.27
3.43

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 18
Mar 17
Mar 16
Shareholder's Funds
593.96
522.27
166.93
111.81
57.68
38.99
27.42
Share Capital
36.44
36.44
31.50
10.50
1.50
1.50
1.50
Total Reserves
557.52
485.84
135.43
101.31
56.18
37.49
25.92
Non-Current Liabilities
10.13
7.29
80.29
25.46
32.73
15.09
15.21
Secured Loans
0.63
0.59
71.82
12.59
28.10
14.03
13.94
Unsecured Loans
0.00
0.00
0.82
7.31
3.68
0.47
2.05
Long Term Provisions
0.68
0.44
4.37
2.44
0.98
0.63
0.37
Current Liabilities
162.85
129.32
166.04
94.61
65.00
54.82
48.60
Trade Payables
142.05
118.42
84.78
51.45
47.76
38.43
28.42
Other Current Liabilities
6.64
4.88
34.62
8.84
3.36
4.99
5.07
Short Term Borrowings
2.77
0.00
44.53
33.92
9.48
9.06
11.49
Short Term Provisions
11.39
6.02
2.12
0.41
4.40
2.34
3.63
Total Liabilities
766.94
658.88
413.26
231.88
155.41
108.90
91.23
Net Block
258.95
204.53
186.31
85.19
31.54
27.76
18.48
Gross Block
297.69
231.14
202.83
97.78
41.13
35.45
24.81
Accumulated Depreciation
38.74
26.60
16.52
12.59
9.60
7.69
6.32
Non Current Assets
296.86
229.31
190.83
110.86
66.45
42.30
24.90
Capital Work in Progress
29.80
2.96
0.20
11.71
30.32
11.42
3.77
Non Current Investment
1.65
1.71
1.43
1.73
2.55
1.43
1.37
Long Term Loans & Adv.
4.25
14.23
1.65
2.68
0.76
0.54
0.48
Other Non Current Assets
2.21
5.87
1.25
9.55
1.28
1.15
0.80
Current Assets
470.08
429.57
216.23
121.04
87.19
66.48
66.17
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
119.17
112.17
60.36
52.34
27.39
19.72
19.64
Sundry Debtors
230.26
163.70
120.69
56.40
49.97
36.49
36.30
Cash & Bank
58.67
99.55
2.68
3.82
1.17
3.58
0.51
Other Current Assets
61.97
11.09
11.73
0.16
8.67
6.68
9.72
Short Term Loans & Adv.
54.02
43.05
20.76
8.31
8.54
6.29
9.48
Net Current Assets
307.23
300.25
50.19
26.42
22.19
11.66
17.57
Total Assets
766.94
658.88
413.26
231.90
155.41
108.90
91.24

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
65.53
-11.93
27.96
27.08
8.46
28.54
9.86
PBT
112.17
91.45
71.73
34.75
28.35
18.68
17.70
Adjustment
14.09
13.64
8.02
10.17
4.43
4.07
2.66
Changes in Working Capital
-36.28
-94.21
-37.61
-9.44
-16.54
12.56
-7.53
Cash after chg. in Working capital
89.98
10.88
42.14
35.49
16.24
35.31
12.83
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-24.45
-22.81
-14.18
-8.41
-7.78
-6.78
-2.98
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-33.04
-120.72
-101.21
-23.94
-25.32
-18.61
-14.23
Net Fixed Assets
-83.19
-30.11
-90.85
-31.67
-21.20
-14.99
Net Investments
-0.05
-0.16
-5.35
-6.72
-5.77
-4.04
Others
50.20
-90.45
-5.01
14.45
1.65
0.42
Cash from Financing Activity
-12.25
140.26
72.11
0.19
14.62
-7.11
4.37
Net Cash Inflow / Outflow
20.24
7.61
-1.14
3.33
-2.23
2.82
-0.01
Opening Cash & Equivalents
10.30
2.68
3.82
0.49
3.14
0.32
0.33
Closing Cash & Equivalent
30.53
10.30
2.68
3.82
0.90
3.14
0.32

Financial Ratios

Standalone /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
163.01
143.34
17.01
106.49
372.75
259.14
181.71
ROA
11.68%
13.42%
16.74%
12.34%
13.99%
12.04%
13.87%
ROE
14.92%
21.07%
39.63%
28.31%
39.03%
36.44%
46.43%
ROCE
20.45%
23.85%
33.01%
26.25%
38.24%
35.91%
35.54%
Fixed Asset Turnover
2.33
2.40
2.27
2.54
4.92
5.32
6.20
Receivable days
116.58
99.79
94.89
100.90
83.83
82.89
86.20
Inventory Days
68.46
60.54
60.39
69.31
45.68
44.82
46.64
Payable days
143.66
135.92
138.36
169.65
99.64
97.78
86.73
Cash Conversion Cycle
41.38
24.41
16.92
0.56
29.87
29.93
46.11
Total Debt/Equity
0.01
0.00
0.85
0.53
0.78
0.68
1.09
Interest Cover
47.50
15.27
13.77
7.22
9.79
6.67
7.92

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.